Haoxi Health Technology Ltd
4 hedge funds and large institutions have $46.4K invested in Haoxi Health Technology Ltd in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
167% more capital invested
Capital invested by funds: $17.4K → $46.4K (+$29K)
100% more funds holding
Funds holding: 2 → 4 (+2)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$15.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$408 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$15.9K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1.47K |
HAO Hedge Fund Activity: Q4 2025 in Review
4 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology Ltd (HAO) for Q4 2025, worth a combined $46.4K — up 167% from $17.4K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HAO positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $17K. The largest seller was Citadel Advisors, exiting entirely with an estimated $15.9K sold.
- 4 institutional investors held Haoxi Health Technology Ltd (HAO) as of Q4 2025, up from 2 in Q3 2025.
- Funds reported $46.4K of Haoxi Health Technology Ltd stock for Q4 2025, up 167% quarter-over-quarter.
- 4 funds opened new Haoxi Health Technology Ltd positions in Q4 2025 and 2 closed out, a net change of +2 holders.
- The largest Haoxi Health Technology Ltd buyer in Q4 2025 was XTX Topco, an estimated $17K added.
- The largest Haoxi Health Technology Ltd seller in Q4 2025 was Citadel Advisors, an estimated $15.9K sold.
Based on aggregated 13F filings for Q4 2025.